UCB, the Belgian drug maker, was yesterday the latest company to join in the rash of mergers among Europe’s medium-sized pharmaceutical groups, with an agreed �.4bn ($5.6bn) cash and share offer for Schwarz Pharma.
比『利』时‘制药’商UCB【昨】日(与Schwarz Pharma达)成‘协’议, 欧‘元(’合56‘亿’美元)现 金[加]股票的出 价收「购」后(者,)令UCB「成为最」新『一』家加入『欧』洲中型制【药集】团 并[购]浪 潮〖的〗企『业。
,,欢迎进入Allbet代理(Allbet Game):www.aLLbetgame.us,欧博官网是欧博集团的官方网站。欧博官网开放Allbet注册、Allbe代理、Allbet电脑客户端、Allbet手机版下载等业务。
The deal, the third of its kind in almost as many days, will create a company with annual turnover of more than �.3bn and increase the number of late-stage products at UCB.
这』是克日第『三宗』并(购)交‘易。’此笔生意营业将“缔”造一家{年}营{业}额〖凌驾33〗亿《欧元的》制《药》企 同时将增「加UCB」开「发末」期产物「的」
网友评论
最新评论
欧博官网欢迎进入欧博官网(Allbet Game):www.aLLbetgame.us,欧博官网是欧博集团的官方网站。欧博官网开放Allbet注册、Allbe代理、Allbet电脑客户端、Allbet手机版下载等业务。人物好喜欢!